Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Domestic Business (Incl. Mail Order Business)		123.92B	136.54B	-	-	-
Domestic Business (Incl. Mail Order Business) Growth		-9.24%	-	-	-	-
International Business		46.84B	44.13B	41.55B	31.14B	22.71B
International Business Growth		6.14%	6.21%	33.44%	37.11%	-17.64%
Others		6.51B	7.06B	6.84B	6.76B	6.38B
Others Growth		-7.78%	3.16%	1.27%	5.86%	-4.67%
Unallocated Adjustment		-11.68B	-14.28B	-14.82B	-13.60B	-12.81B
Domestic Business		-	-	124.24B	121.96B	125.16B
Domestic Business Growth		-	-	1.87%	-2.56%	-8.70%
Mail Order Business		-	-	8.44B	8.99B	9.07B
Mail Order Business Growth		-	-	-6.17%	-0.79%	-7.19%
Total		165.60B	173.46B	166.26B	155.25B	150.51B
Total Growth		-4.53%	4.33%	7.09%	3.15%	-10.44%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Japan		120.42B	131.16B	126.58B	125.51B	129.05B
Japan Growth		-8.19%	3.62%	0.85%	-2.74%	-8.75%
USA		21.25B	17.06B	16.47B	13.01B	8.14B
USA Growth		24.56%	3.54%	26.64%	59.86%	-13.25%
China		-	13.65B	12.48B	10.07B	7.65B
China Growth		-	9.37%	24.00%	31.62%	-23.89%
Southeast Asia		-	7.93B	7.49B	4.21B	3.17B
Southeast Asia Growth		-	5.86%	78.15%	32.72%	-30.84%
Others		23.93B	3.65B	3.23B	2.46B	2.51B
Others Growth		555.19%	13.27%	31.31%	-2.15%	-4.34%
Total		165.60B	173.45B	166.26B	155.25B	150.51B
Total Growth		-4.53%	4.33%	7.09%	3.15%	-10.44%

Source: S&P Global Market Intelligence.